BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25880250)

  • 1. Quality of Life in Young Adult Patients with a Cardiogenetic Condition Receiving an ICD for Primary Prevention of Sudden Cardiac Death.
    Verkerk AJ; Vermeer AM; Smets EM; Dekker LR; Wilde AA; Van Langen IM; Christiaans I; Nieuwkerk PT
    Pacing Clin Electrophysiol; 2015 Jul; 38(7):870-7. PubMed ID: 25880250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender disparities in anxiety and quality of life in patients with an implantable cardioverter-defibrillator.
    Habibović M; van den Broek KC; Theuns DA; Jordaens L; Alings M; van der Voort PH; Pedersen SS
    Europace; 2011 Dec; 13(12):1723-30. PubMed ID: 21821854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease.
    Ingles J; Sarina T; Kasparian N; Semsarian C
    Int J Cardiol; 2013 Oct; 168(4):3779-84. PubMed ID: 23835269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of patient and partner quality of life and health outcomes in the first year after an implantable cardioverter defibrillator (ICD).
    Dougherty CM; Fairbanks AM; Eaton LH; Morrison ML; Kim MS; Thompson EA
    J Behav Med; 2016 Feb; 39(1):94-106. PubMed ID: 26345262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.
    Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring treatment expectations in patients with an implantable cardioverter-defibrillator using the EXPECT-ICD scale.
    Habibović M; Pedersen SS; van den Broek KC; Denollet J
    Europace; 2014 Jul; 16(7):1022-7. PubMed ID: 24596397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender disparities in quality of life and psychological disturbance in patients with implantable cardioverter-defibrillators.
    Rahmawati A; Chishaki A; Sawatari H; Tsuchihashi-Makaya M; Ohtsuka Y; Nakai M; Miyazono M; Hashiguchi N; Sakurada H; Takemoto M; Mukai Y; Inoue S; Sunagawa K; Chishaki H
    Circ J; 2013; 77(5):1158-65. PubMed ID: 23337265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term efficacy of a telephone intervention by expert nurses after an implantable cardioverter defibrillator.
    Dougherty CM; Lewis FM; Thompson EA; Baer JD; Kim W
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1594-602. PubMed ID: 15613121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and financial impact of implantable cardioverter-defibrillator patients without interventions 5 years after implantation.
    Reichlin T; Kühne M; Sticherling C; Osswald S; Schaer B
    QJM; 2011 Oct; 104(10):849-57. PubMed ID: 21624895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era.
    Groeneveld PW; Matta MA; Suh JJ; Yang F; Shea JA
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):463-71. PubMed ID: 17437568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.
    Thylén I; Dekker RL; Jaarsma T; Strömberg A; Moser DK
    J Psychosom Res; 2014 Aug; 77(2):122-7. PubMed ID: 25077853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    You JJ; Woo A; Ko DT; Cameron DA; Mihailovic A; Krahn M
    Am Heart J; 2007 Nov; 154(5):899-907. PubMed ID: 17967596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of secondary prevention of anxiety and distress in a German sample of patients with an implantable cardioverter defibrillator.
    Crössmann A; Schulz SM; Kühlkamp V; Ritter O; Neuser H; Schumacher B; Bauer W; Pauli P
    Psychosom Med; 2010 Jun; 72(5):434-41. PubMed ID: 20410252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy.
    Hua W; Niu H; Fan X; Ding L; Xu YZ; Wang J; Chen K; Wang F; Zhang S;
    J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S5-9. PubMed ID: 23140347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
    Forleo GB; Della Rocca DG; Papavasileiou LP; Panattoni G; Sergi D; Duro L; Mahfouz K; Magliano G; Santini L; Romeo F
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):779-84. PubMed ID: 21941203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy.
    Knackstedt C; Arndt M; Mischke K; Marx N; Nieman F; Kunert HJ; Schauerte P; Norra C
    Heart Vessels; 2014 May; 29(3):364-74. PubMed ID: 23732755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.
    Chen TB; Cheng KA; Gao P; Cheng ZW; Fan JB; Jiang XC; Fang Q
    Chin Med J (Engl); 2010 Apr; 123(7):848-51. PubMed ID: 20497676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.